CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital